BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

404 related articles for article (PubMed ID: 25992407)

  • 1. Shape-mediated biological effects of mesoporous silica nanoparticles.
    Hao N; Li L; Tang F
    J Biomed Nanotechnol; 2014 Oct; 10(10):2508-38. PubMed ID: 25992407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mesoporous silica nanoparticles: synthesis, biocompatibility and drug delivery.
    Tang F; Li L; Chen D
    Adv Mater; 2012 Mar; 24(12):1504-34. PubMed ID: 22378538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mesoporous silica nanoparticles for therapeutic/diagnostic applications.
    Jafari S; Derakhshankhah H; Alaei L; Fattahi A; Varnamkhasti BS; Saboury AA
    Biomed Pharmacother; 2019 Jan; 109():1100-1111. PubMed ID: 30551360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mesoporous silica nanoparticles for tissue-engineering applications.
    Chen L; Zhou X; He C
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2019 Nov; 11(6):e1573. PubMed ID: 31294533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biocompatibility of mesoporous silica nanoparticles.
    Asefa T; Tao Z
    Chem Res Toxicol; 2012 Nov; 25(11):2265-84. PubMed ID: 22823891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The shape effect of mesoporous silica nanoparticles on biodistribution, clearance, and biocompatibility in vivo.
    Huang X; Li L; Liu T; Hao N; Liu H; Chen D; Tang F
    ACS Nano; 2011 Jul; 5(7):5390-9. PubMed ID: 21634407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mesoporous silica nanoparticles: synthesis, classification, drug loading, pharmacokinetics, biocompatibility, and application in drug delivery.
    Li Z; Zhang Y; Feng N
    Expert Opin Drug Deliv; 2019 Mar; 16(3):219-237. PubMed ID: 30686075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biomedical application of mesoporous silica nanoparticles as delivery systems: a biological safety perspective.
    Hosseinpour S; Walsh LJ; Xu C
    J Mater Chem B; 2020 Nov; 8(43):9863-9876. PubMed ID: 33047764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo bio-safety evaluations and diagnostic/therapeutic applications of chemically designed mesoporous silica nanoparticles.
    Chen Y; Chen H; Shi J
    Adv Mater; 2013 Jun; 25(23):3144-76. PubMed ID: 23681931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biosafety of mesoporous silica nanoparticles; towards clinical translation.
    Lérida-Viso A; Estepa-Fernández A; García-Fernández A; Martí-Centelles V; Martínez-Máñez R
    Adv Drug Deliv Rev; 2023 Oct; 201():115049. PubMed ID: 37573951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The shape effect of magnetic mesoporous silica nanoparticles on endocytosis, biocompatibility and biodistribution.
    Shao D; Lu MM; Zhao YW; Zhang F; Tan YF; Zheng X; Pan Y; Xiao XA; Wang Z; Dong WF; Li J; Chen L
    Acta Biomater; 2017 Feb; 49():531-540. PubMed ID: 27836804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of the shape of mesoporous silica nanoparticles on cellular uptake and cell function.
    Huang X; Teng X; Chen D; Tang F; He J
    Biomaterials; 2010 Jan; 31(3):438-48. PubMed ID: 19800115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Shape matters when engineering mesoporous silica-based nanomedicines.
    Hao N; Li L; Tang F
    Biomater Sci; 2016 Apr; 4(4):575-91. PubMed ID: 26818852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multifunctional mesoporous silica nanocomposite nanoparticles for theranostic applications.
    Lee JE; Lee N; Kim T; Kim J; Hyeon T
    Acc Chem Res; 2011 Oct; 44(10):893-902. PubMed ID: 21848274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Silica nanoparticle surface chemistry: An important trait affecting cellular biocompatibility in two and three dimensional culture systems.
    Hasany M; Taebnia N; Yaghmaei S; Shahbazi MA; Mehrali M; Dolatshahi-Pirouz A; Arpanaei A
    Colloids Surf B Biointerfaces; 2019 Oct; 182():110353. PubMed ID: 31336281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tailored Mesoporous Silica Nanoparticles for Controlled Drug Delivery: Platform Fabrication, Targeted Delivery, and Computational Design and Analysis.
    She X; Chen L; Yi Z; Li C; He C; Feng C; Wang T; Shigdar S; Duan W; Kong L
    Mini Rev Med Chem; 2018; 18(11):976-989. PubMed ID: 27145854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mesoporous silica nanoparticles for intracellular controlled drug delivery.
    Vivero-Escoto JL; Slowing II; Trewyn BG; Lin VS
    Small; 2010 Sep; 6(18):1952-67. PubMed ID: 20690133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis of mesoporous silica nanoparticles.
    Wu SH; Mou CY; Lin HP
    Chem Soc Rev; 2013 May; 42(9):3862-75. PubMed ID: 23403864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TPGS functionalized mesoporous silica nanoparticles for anticancer drug delivery to overcome multidrug resistance.
    Zhao P; Li L; Zhou S; Qiu L; Qian Z; Liu X; Cao X; Zhang H
    Mater Sci Eng C Mater Biol Appl; 2018 Mar; 84():108-117. PubMed ID: 29519418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mesoporous silica nanorods for improved oral drug absorption.
    Zheng N; Li J; Xu C; Xu L; Li S; Xu L
    Artif Cells Nanomed Biotechnol; 2018 Sep; 46(6):1132-1140. PubMed ID: 28783976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.